Covance, Inc

Article Abstract:

The price appreciation potential of the shares of Covance Inc. for the years 2010-2012 is discussed. The Princeton, New Jersey-based company is one of the world's leading contract research organizations, and benefits from development outsourcing demand in the pharmaceutical industry.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Stock highlight: Covance, Inc. (CVD-38.58)

Article Abstract:

A leading contract research organization, Covance, is into marketing pre-clinical lab services to large pharmaceutical companies. They also undertake toxicology studies. A debt-free balance sheet, robust cash flow and over $144 million in cash assets make the stock attractive.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Mylan Inc

Article Abstract:

The shares of Mylan Inc. have a substantial price appreciation potential over the 2010-2012 timeframe. The Canonsburg, Pennsylvania-based company is a manufacturer of prescription generic drugs and brand-name dermatological products.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: